About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
© 2023 © 2020 Genprex Inc. All Rights Reserved.
About Us
Scientific Advisory Board
Jack A. Roth, MD, FACS
SAB Chairman
George K. Gittes, MD
SAB Board Member
Pasi Antero Jänne, MD, PhD
SAB Board Member
Tony S.K. Mok, MD, FRCP
SAB Board Member
George Simon, MD, FACS
SAB Board Member